Publication: Femoral bone mineral density and bone mineral content in bromocriptine-treated pregnant and lactating rats
Issued Date
2010-01-01
Resource Type
ISSN
18806546
Other identifier(s)
2-s2.0-73549105242
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Physiological Sciences. Vol.60, No.1 (2010), 1-8
Suggested Citation
Panan Suntornsaratoon, Kannikar Wongdee, Nateetip Krishnamra, Narattaphol Charoenphandhu Femoral bone mineral density and bone mineral content in bromocriptine-treated pregnant and lactating rats. Journal of Physiological Sciences. Vol.60, No.1 (2010), 1-8. doi:10.1007/s12576-009-0059-1 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/28808
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Femoral bone mineral density and bone mineral content in bromocriptine-treated pregnant and lactating rats
Other Contributor(s)
Abstract
Since hyperprolactinemia was found to induce osteopenia in the metaphysis of long bone in non-mated female rats, pregnant and lactating rats with sustainedly high plasma prolactin (PRL) levels might also exhibit some changes in their long bones. We performed a longitudinal study in pregnant, lactating and post-weaning rats, using dual-energy X-ray absorptiometry to demonstrate site-specific changes (i.e., metaphysis vs. diaphysis) in femoral bone mineral density (BMD) and content (BMC). The results showed that femoral metaphyseal BMD and BMC were higher when compared to their age-matched controls during pregnancy, before decreasing in late lactation and post-weaning. On the other hand, femoral diaphyseal BMC increased during pregnancy, early lactating and mid-lactating periods without change during late lactation and post-weaning. After 7 days of bromocriptine administration which inhibited endogenous PRL secretion, the lactation-induced increases in BMC during early and mid-lactating periods were abolished. Moreover, a decrease in metaphyseal BMD during late lactation was restored to the control levels by bromocriptine. However, bromocriptine did not antagonize the pregnancy-induced increases in BMD and BMC. It could be concluded that the effect of PRL on bone was variable during the reproductive periods. While having no effect on femoral BMD and BMC during pregnancy, PRL was responsible for bone gain in early and mid-lactating periods, but induced bone loss during late lactating period. © 2009 The Physiological Society of Japan and Springer.
